372 related articles for article (PubMed ID: 27320643)
1. Intestinal permeation enhancers for oral peptide delivery.
Maher S; Mrsny RJ; Brayden DJ
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
[TBL] [Abstract][Full Text] [Related]
2. Formulation strategies to improve the efficacy of intestinal permeation enhancers
Maher S; Brayden DJ
Adv Drug Deliv Rev; 2021 Oct; 177():113925. PubMed ID: 34418495
[TBL] [Abstract][Full Text] [Related]
3. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
4. Intestinal permeation enhancers: Lessons learned from studies using an organ culture model.
Danielsen EM
Biochim Biophys Acta Biomembr; 2021 Jan; 1863(1):183474. PubMed ID: 32946886
[TBL] [Abstract][Full Text] [Related]
5. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
Aguirre TA; Teijeiro-Osorio D; Rosa M; Coulter IS; Alonso MJ; Brayden DJ
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):223-241. PubMed ID: 26921819
[TBL] [Abstract][Full Text] [Related]
6. Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans.
Maher S; Geoghegan C; Brayden DJ
Expert Opin Drug Deliv; 2021 Feb; 18(2):273-300. PubMed ID: 32937089
[TBL] [Abstract][Full Text] [Related]
7. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
8. [Methodologies for regulation of intestinal absorption of biologically active peptides].
Fujita T; Muranishi S
Nihon Rinsho; 1998 Mar; 56(3):589-94. PubMed ID: 9549341
[TBL] [Abstract][Full Text] [Related]
9. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET).
Walsh EG; Adamczyk BE; Chalasani KB; Maher S; O'Toole EB; Fox JS; Leonard TW; Brayden DJ
Ther Deliv; 2011 Dec; 2(12):1595-610. PubMed ID: 22833984
[TBL] [Abstract][Full Text] [Related]
11. Evaluation in pig of an intestinal administration device for oral peptide delivery.
Berg S; Uggla T; Antonsson M; Nunes SF; Englund M; Rosengren L; Fahraj M; Wu X; Govender R; Söderberg M; Janzén D; Van Zuydam N; Hugerth A; Larsson A; Abrahmsén-Alami S; Abrahamsson B; Davies N; Bergström CAS
J Control Release; 2023 Jan; 353():792-801. PubMed ID: 36493948
[TBL] [Abstract][Full Text] [Related]
12. Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues.
Lundquist P; Artursson P
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):256-276. PubMed ID: 27496705
[TBL] [Abstract][Full Text] [Related]
13. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
[TBL] [Abstract][Full Text] [Related]
14. Using peptides to increase transport across the intestinal barrier.
Sánchez-Navarro M; Garcia J; Giralt E; Teixidó M
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):355-366. PubMed ID: 27155131
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic analysis of chemical permeation enhancers for oral drug delivery.
Whitehead K; Mitragotri S
Pharm Res; 2008 Jun; 25(6):1412-9. PubMed ID: 18311478
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and mechanism of HP-β-CD-PEI polymers as absorption enhancers on the intestinal absorption of poorly absorbable drugs in rats.
Zhang H; Huang X; Zhang Y; Gao Y
Drug Dev Ind Pharm; 2017 Mar; 43(3):474-482. PubMed ID: 27892724
[TBL] [Abstract][Full Text] [Related]
17. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
[TBL] [Abstract][Full Text] [Related]
18. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
Maher S; Leonard TW; Jacobsen J; Brayden DJ
Adv Drug Deliv Rev; 2009 Dec; 61(15):1427-49. PubMed ID: 19800376
[TBL] [Abstract][Full Text] [Related]
20. Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects.
Richard J
Ther Deliv; 2017 Jul; 8(8):663-684. PubMed ID: 28730934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]